论文部分内容阅读
目的:探讨前列地尔联合金水宝胶囊治疗糖尿病肾病(DN)的临床疗效。方法:将住院治疗的2型糖尿病患者40例随机分为对照组和治疗组,对照组20例和治疗组20例。2组均服用金水宝胶囊3粒/次,3次/d,治疗组静脉滴注前列地尔20μg/d。结果:治疗组患者生化指标及临床症状均明显改善,与对照组比较有明显差异(p<0.05)。结论:前列地尔联合金水宝胶囊方案治疗2型糖尿病疗效明显优于单用金水宝胶囊。
Objective: To investigate the clinical efficacy of alprostadil combined with Jinshuibao capsule in the treatment of diabetic nephropathy (DN). Methods: Forty patients with type 2 diabetes mellitus admitted to hospital were randomly divided into control group and treatment group, 20 cases in control group and 20 cases in treatment group. 2 groups were taken Jin Shui Bao capsule 3 capsules / time, 3 times / d, the treatment group intravenous alprostadil 20μg / d. Results: The biochemical indexes and clinical symptoms of the treatment group were significantly improved, compared with the control group (p <0.05). Conclusion: Alprostadil combined Jinshuibao capsule treatment of type 2 diabetes mellitus is superior to the single Jinshuibao capsule.